Clinical Trial Update: A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer [NA]

View source ↗

Summary

An ongoing single-arm multicenter trial is evaluating preoperative neoadjuvant mFOLFOX6 chemotherapy in combination with a PD-1 monoclonal antibody for MSS/pMMR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PD-1 monoclonal antibody
• mFOLFOX6 chemotherapy regimen (FOLFOX6 consisting of oxaliplatin, leucovorin, and 5-fluorouracil)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Locally Advanced Rectal Cancer (LARC) | NA | Status: ACTIVE_NOT_RECRUITING